Home › Rheumatoid Arthritis › Texas › Arlington
Rheumatoid Arthritis clinical trials in Arlington, TX
4 studies for Rheumatoid Arthritis are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RecruitingPhase 2
- Precision Comprehensive Clinical Research Solutions, Colleyville · 10 mi away
RA-PRO PRAGMATIC TRIAL
RecruitingPhase 3
- Heritage Rheumatology and Arthritis Care, Colleyville · 10 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Arlington, Arlington
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Recruiting
- Precision Comprehensive Clinical Research Solutions, Colleyville · 10 mi away
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX12 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Miami, FL8 studies
- Plantation, FL7 studies
- Altoona, PA7 studies
- Dallas, TX7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Mesquite, TX6 studies
- San Diego, CA6 studies
- Ann Arbor, MI5 studies
Other studies in Arlington
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer4 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Chronic Kidney Disease4 studies
- High Blood Pressure4 studies
- Sjögren's Disease4 studies
- Lupus3 studies
- Breast Cancer3 studies
- Ulcerative Colitis3 studies
- Bladder Cancer3 studies
- Cirrhosis3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.